Latest filing published 22 Sept 2026 for GSK plc, €363.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Elizabeth (Liz) McKee Anderson: trading record in brief
This profile gathers the share dealings of Elizabeth (Liz) McKee Anderson in GSK plc. The record holds 13 filings, for trades running from 20 March 2024 to 18 September 2026.
Every open-market trade on record is a purchase: 13 purchases worth €232k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 4 purchases and no sales.
A typical purchase (the median) is worth €11k. Of 11 purchases, 11 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 22 September 2026, the filings show an open-market purchase worth €27k in GSK plc. Filings reach the RNS (LSE) feed a median of 3 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Elizabeth (Liz) McKee Anderson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 626 shares@ £0.4985New York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:6d07555a-8fe0-4cf5-bc3a-79471d424d47-1Canonical exit: 17 Dec 2026 (T+90)
- 789 shares@ £50.69080.0001% mcap96.7% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:9632737-1Canonical exit: 20 Sept 2026 (T+90)
- 789 shares@ £50.690729.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:1cabaef6-2e05-4f58-a412-24a2f7509642-1Canonical exit: 20 Sept 2026 (T+90)
- 196 shares@ £51.795910.5% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:c2055913-103f-4927-b6f8-8f0835af9e8e-2Canonical exit: 18 Jun 2026 (T+90)
- 201 shares@ £48.55729.9% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5a98a0c7-d756-450b-83e9-f26937fe1a0f-1Canonical exit: 19 Mar 2026 (T+90)
- 240 shares@ £40.737512.6% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5830475-1Canonical exit: 18 Dec 2025 (T+90)
- 258 shares@ £37.895314.6% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5708028-2Canonical exit: 18 Sept 2025 (T+90)
- 258 shares@ £37.895314.6% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5707630-2Canonical exit: 18 Sept 2025 (T+90)
- 248 shares@ £39.274221.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5584787-2Canonical exit: 18 Jun 2025 (T+90)
- 272 shares@ £33.808820.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5479029-2Canonical exit: 20 Mar 2025 (T+90)
- 223 shares@ £41.013533.7% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5362280-1Canonical exit: 22 Dec 2024 (T+90)
- 225 shares@ £40.764450.2% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5235239-1Canonical exit: 18 Sept 2024 (T+90)
- 219 shares@ £41.9041100.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5116598-8Canonical exit: 18 Jun 2024 (T+90)
13 of 13 declarations
